(Q33410206)

English

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

7

object named as

Hyo Song Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

6

object named as

Sun Min Lim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Hye Ryun Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hyung Soon Park

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Woo Sun Kwon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ji Hyun Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yusuke Tanigawara

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

8 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

825-835

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Kidney Cancer Working Group report.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Overall survival and updated results from a phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2258-Y

21 January 2018

Identifiers

10.1007/S00280-013-2258-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24013576%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33410206&oldid=2195334277"